GSK-113172

Study Sponsor: GSK

Study Title

Study of GSK2302024A Antigen-Specific Cancer Immunotherapeutic combined with standard neoadjuvant treatment in patients with WT1-positive primary invasive breast cancer

Medicine or Vaccine (generic name)

GSK2302024A

Sponsor Identification Number

113172

Trial Registry Identification Number(#'s)

NCT01220128 2010-019909-42

Medical Condition

Neoplasms, Breast

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=113172

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01220128

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2010-019909-42

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

October 2018